LFSC Holdings

40 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.

40 lines in the fund's latest file.

Top 25 Holdings

#HoldingWeightShares (as reported)Value (as reported)
1Corcept Therapeutics Inc7.77%75,436$9.1M
2LivaNova PLC6.83%105,381$8.0M
3Travere Therapeutics Inc6.60%140,245$7.7M
4Cogent Biosciences Inc6.07%235,467$7.1M
5Guardant Health Inc5.42%37,716$6.4M
6Spyre Therapeutics Inc4.92%71,476$5.8M
7Replimune Group Inc4.60%408,338$5.4M
8Billiontoone Inc4.44%54,115$5.2M
9TransMedics Group Inc3.58%50,164$4.2M
10VeraDermics Inc3.51%37,030$4.1M
11Mirum Pharmaceuticals Inc3.49%49,574$4.1M
12Axsome Therapeutics Inc3.44%22,951$4.0M
13Cytokinetics Inc3.28%62,691$3.8M
14Savara Inc2.86%677,875$3.4M
15ICU Medical Inc2.75%20,343$3.2M
16United Therapeutics Corp2.66%5,670$3.1M
17Twist Bioscience Corp2.50%18,580$2.9M
18Dianthus Therapeutics Inc2.37%32,523$2.8M
19Trevi Therapeutics Inc2.24%198,086$2.6M
20Viridian Therapeutics Inc2.20%138,752$2.6M
21Palvella Therapeutics Inc2.00%17,958$2.3M
22Ceribell Inc1.88%91,993$2.2M
23Nektar Therapeutics1.77%52,967$2.1M
24Corvus Pharmaceuticals Inc1.53%172,119$1.8M
25Alphatec Holdings Inc1.35%150,811$1.6M

Country Weights

  • United States: 93.17%
  • United Kingdom: 6.83%

Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.